BALB/cJ and C57BL/6J Mice to Support Different Infection Models
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Naval Medical Research Command’s Combat Wound Infections Division intends to award a Blanket Purchase Agreement to Charles River Laboratories and The Jackson Laboratory for the supply of specific-pathogen-free female BALB/cJ and C57BL/6J laboratory mice. These mice, aged 49–56 days and weighing 12–16 grams, are required for approximately forty-three in vivo experiments planned between August 2026 and August 2027. The contract emphasizes that the animals must be free from infectious diseases, untreated with systemic or topical antimicrobials, and sourced specifically from these two vendors to maintain the integrity of ongoing research, as baseline data and controls have already been established using these exact strains. While this is not a request for competitive proposals, other firms capable of supplying the exact genetic strains without introducing phenotypic or genotypic variations may submit a written Capability Statement by June 19, 2026. Submissions must demonstrate the ability to provide the specified strains, approval by the Walter Reed Army Institute of Research, and assurance that the animals are specific-pathogen-free and antimicrobial-free. The government retains full discretion whether to compete the acquisition based on the responses received. The place of performance is Silver Spring, Maryland, and the point of contact for the solicitation is Priscilla Vania Harrison.
General Info
Agency
NAICS
Place of Performance
Silver Spring, MD, 20910, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Description: The Combat Wound Infections Division (CWID) at Naval Medical Research Command (NMRC), intends to award a Blanket Purchase Agreement (BPA) to Charles River Laboratories (CRL) and The Jackson Laboratory (JAX) under the authority of FAR 13.106-1(b)(1), “Soliciting from a Single Source” for purchases not exceeding the Simplified Acquisition Threshold (SAT).The Naval Medical Research Command (NMRC) requires a continuous, flexible supply of up to 5,160 specific-pathogen-free (SPF) laboratory research mice. The requirement consists of female BALB/cJ and C57BL/6J strains, aged 49–56 days, and weighing 12–16 grams. The vendor must guarantee that all models are free from infectious diseases and have not received any prior systemic or topical antimicrobials. Delivery is required on a indefinite-delivery basis to support approximately forty-three (43) in vivo experiments scheduled between August 2026 and August 2027. Because CRL and JAX are approved by Walter Reed Army Institute of Research and planned studies are continuations of ongoing research, study baselines and control determinations have already been established using CRL BALB/cJ and JAX C57BL/6J mice, it is critical to ensure the animals are procured from these exact sources. Sourcing from alternative breeders would introduce unacceptable phenotypic and genotypic variation into the upcoming studies, which would invalidate historical data and jeopardize the integrity of the research.
This notice of intent is not a request for competitive proposals. However, any firm that believes it can meet this requirement without introducing the aforementioned phenotypic/genotypic variation to the established baselines may submit a written Capability Statement. Responses must include:
- Evidence of the ability to provide the exact genetic strains (BALB/cJ C57BL/6J).
- Evidence that they have been approved by Walter Reed Army Institute of Research.
- Confirmation of the ability to meet the SPF and “antimicrobial-free” guarantees.
Responses must be submitted to the Contracting Officer at priscilla.v.harrison.civ@health.mil no later than June 19, 2026.
A determination by the Government not to compete this proposed action based upon responses to this notice is solely within the discretion of the Government.